Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy

Active, not recruitingOBSERVATIONAL

Enrollment

273

Participants

Timeline

Start Date

October 4, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Adult Brain TumorLung CancerRadiation Toxicity

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

All Listed Sponsors

lead

Ohio State University Comprehensive Cancer Center

OTHER